USE OF DHA IN THE FORM OF PHOSPHOLIPIDS FOR THE PREPARATION OF A COMPOSITION THAT IS INTENDED FOR THE TREATMENT OF RESPIRATORY FAILURE

摘要

Use of a phospholipid for the preparation of a composition to treat and/or prevent respiratory insufficiency of a patient, particularly human being. Use of a phospholipid of formula R1-O-CH 2-CH(-O-R2)-CH 2(-O-P(=O)(O ->)(O-R3)) for the preparation of a composition to treat and/or prevent respiratory insufficiency of a patient, particularly human being. R1, R2 : docosahexaenoyl residue or optionally saturated 8-24C acyl residue (preferably palmitate, stearate, oleate, linoleate or arachidonate); and R3 : choline (preferred), serine, ethanolamine, inositol or glycerol residue or H. Provided that at least one of R1 and R2 (preferably R2) is a docosahexaenoyl residue. ACTIVITY : Respiratory-Gen.; Anabolic. MECHANISM OF ACTION : None given.